Epsilon Healthcare Limited (ASX:EPN)
0.0320
-0.0010 (-3.03%)
Jan 30, 2026, 3:07 PM AEST
Epsilon Healthcare Revenue
Epsilon Healthcare had revenue of 3.40M AUD in the half year ending June 30, 2025, with 2.75% growth. This brings the company's revenue in the last twelve months to 6.13M, down -1.25% year-over-year. In the year 2024, Epsilon Healthcare had annual revenue of 5.60M, down -15.81%.
Revenue (ttm)
6.13M
Revenue Growth
-1.25%
P/S Ratio
2.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.60M | -1.05M | -15.81% |
| Dec 31, 2023 | 6.65M | 2.00M | 42.99% |
| Dec 31, 2022 | 4.65M | -846.35K | -15.39% |
| Dec 31, 2021 | 5.50M | -1.46M | -20.93% |
| Dec 31, 2020 | 6.95M | 2.16M | 45.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 124.04M |
| Little Green Pharma | 38.49M |
| IDT Australia | 19.77M |
| ECS Botanics Holdings | 19.36M |
| Elixinol Wellness | 15.85M |
| Peak Processing | 15.49M |
| Cann Group | 13.25M |
| Percheron Therapeutics | 1.80M |